Is it time to sell Slater & Gordon Limited?

After a strong run, it could be time to reduce your exposure to legal eagle Slater & Gordon Limited (ASX:SGH).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a very busy start to the year at Australia's largest law firm, Slater & Gordon Limited (ASX: SGH).

In addition to its huge $1.2 billion acquisition of the Professional Services Division (PSD) of embattled UK holding company, Quindell Plc; Slater & Gordon has posted strong organic growth and paid out its biggest ever interim dividend.

For investors, this has resulted in a 20% surge in share price in a little over three months – doubling the broader S&P/ASX200's (ASX: XJO) (Index: ^AXJO) 9.5% gain.

However, with shares now up 400% in five years and a very big acquisition yet to be digested, now could be the ideal time to consider taking some profit off the table.

Currently, Slater & Gordon shares trade at a price-earnings ratio of 26.

Here's why the investment case has changed…

As with many companies pursuing a 'roll-up growth strategy' (whereby public companies buy smaller rivals to consolidate the industry and derive operational synergies), it's best to be there for a good time, not a long time.

Indeed, with Slater & Gordon taking on such a large acquisition, arguably, the short-to medium-term outlook and forecast for earnings per share (EPS) growth has become more uncertain, subjective and complicated.

For example, at today's prices, even if Slater & Gordon can grow EPS at 15% for the next three years, and 10% between years 3 and 10 (which is a very tall order for any company over the long-haul), the value risk-reward proposition is not skewed in  favour of investors, in my opinion.

All considered, from today's prices, I do not expect Slater & Gordon shares to handily outperform the market. I believe it's less likely to do so now, than it was three months ago.

Should you Buy, Hold or Sell?

Shareholders on the company's register at 7pm (Melbourne time) on Thursday 2 April 2015, will have the right to buy two new shares for every three Slater & Gordon shares they held, at a discounted price of $6.37 per unit. The money raised from this retail offer, as well as the associated institutional share issue and debt raising, will be used to acquire Quindell's PSD.

As a shareholder in Slater & Gordon, I'll take part in the offer for the discounted shares (remember: so long as the market price remains above the offer price for new shares there's an opportunity for investors to make an arbitrage profit by buying the cheap shares and selling them on market).

However, looking ahead into the near future, I'll likely start to take a large portion of my paper profits off the table and reduce my exposure. Whilst the potentially significant upside from the PSD acquisition could be realised sooner rather than later, I think Slater & Gordon's valuation has become somewhat stretched given the uncertainty looking ahead.

Motley Fool Contributor Owen Raszkiewicz owns shares in Slater & Gordon. You can follow Owen on Twitter @ASXinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.”

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »